Page 3 - Affinity Asset Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Affinity asset advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Affinity Asset Advisors Today - Breaking & Trending Today

Rezolute, Inc. (NASDAQ:RZLT) Insider Brian Kenneth Roberts Purchases 7,500 Shares

Rezolute, Inc. (NASDAQ:RZLT – Get Free Report) insider Brian Kenneth Roberts bought 7,500 shares of the company’s stock in a transaction on Thursday, May 23rd. The stock was bought at an average cost of $2.69 per share, with a total value of $20,175.00. Following the completion of the purchase, the insider now owns 50,052 shares […] ....

United States , Brian Kenneth Roberts , Maxim Group , Rezolute Inc , Acadian Asset Management , Vanguard Group Inc , Affinity Asset Advisors , Rosalind Advisors Inc , Virtu Financial , Get Free Report , Kenneth Roberts , Asset Management , Rezolute Daily ,

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $14.94 Consensus PT from Brokerages

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price objective […] ....

Affinity Asset Advisors , Terns Pharmaceuticals , Terns Pharmaceuticals Price Performance , Analyst Recommendations For Terns Pharmaceuticals , Terns Pharmaceuticals Company Profile , Vivo Opportunity Llc , News Ratings For Terns Pharmaceuticals Daily , Insider Activity At Terns Pharmaceuticals , Terns Pharmaceuticals Inc , Get Free Report , Vivo Opportunity , Fire Capital , Asset Advisors , Get Free , Terns Pharmaceuticals Daily ,

Insider Buying: Zura Bio Limited (NASDAQ:ZURA) Director Acquires 80,000 Shares of Stock

Zura Bio Limited (NASDAQ:ZURA – Get Free Report) Director Van Amstel Arnout Ploos acquired 80,000 shares of the firm’s stock in a transaction that occurred on Friday, May 17th. The shares were bought at an average price of $6.20 per share, with a total value of $496,000.00. Following the acquisition, the director now directly owns […] ....

Van Amstel Arnout Ploos , Zura Bio , Piper Sandler , Eisler Capital , Affinity Asset Advisors , Armistice Capital , Zura Bio Limited , Forefront Analytics , Get Free Report , Director Van Amstel Arnout Ploos , Bio Trading Down , Asset Advisors , Bio Limited , Zura Bio Daily ,

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) have earned an average rating of “Moderate Buy” from the eight research firms that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month […] ....

Vivo Opportunity Llc , Terns Pharmaceuticals Inc , Affinity Asset Advisors , Terns Pharmaceuticals Stock Performance , News Ratings For Terns Pharmaceuticals Daily , Analyst Recommendations For Terns Pharmaceuticals , Terns Pharmaceuticals , Insider Transactions At Terns Pharmaceuticals , Get Free Report , Vivo Opportunity , Fire Capital , Asset Advisors , Get Free , Terns Pharmaceuticals Daily ,

Elevation Oncology, Inc. (NASDAQ:ELEV) Given Consensus Recommendation of "Buy" by Analysts

Elevation Oncology, Inc. (NASDAQ:ELEV – Get Free Report) has been given a consensus recommendation of “Buy” by the six research firms that are covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have covered the stock in the last year […] ....

Darwin Global Management Ltd , Sg Americas Securities , Affinity Asset Advisors , Vanguard Group Inc , Artal Group , Elevation Oncology Inc , Elevation Oncology , Get Free Report , Asset Advisors , Darwin Global Management , Get Free , Elevation Oncology Daily ,